Antithrombin Replacement During Extracorporeal Membrane Oxygenation

Chung, 2000, ECMO Extracorporeal Cardiopulmonary Support in Critical Care, Second Edition, 269

Graves, 1996, Anticoagulation practices during neonatal extracorporeal membrane oxygenation: survey results, Perfusion, 11, 461, 10.1177/026765919601100607

Oliver, 2009, Anticoagulation and coagulation management for ECMO, Semin Cardiothorac Vasc Anesth, 13, 154, 10.1177/1089253209347384

Rosenberg, 1989, Biochemistry of heparin antithrombin interactions, and the physiologic role of this natural anticoagulant mechanism, Am J Med, 87, 2S, 10.1016/0002-9343(89)80523-6

Villaneuva, 1977, Evidence for a heparin-induced conformational change on antithrombin III, Biochem Biophys Res Commun, 74, 803, 10.1016/0006-291X(77)90374-6

Urlesberger, 1996, Activation of the clotting system during extracorporeal membrane oxygenation in term newborn infants, J Pediatr, 129, 264, 10.1016/S0022-3476(96)70252-4

Agati, 2006, Use of a novel anticoagulation strategy during ECMO in a pediatric population: single-center experience, ASAIO J, 52, 513

Despotis, 1995, The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation, J Thorac Cardiovasc Surg, 110, 46, 10.1016/S0022-5223(05)80008-X

Avidan, 2005, A phase III, double-blind, placebo-controlled, multicenter study on the efficacy of recombinant human antithrombin in heparin-resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypass, Anesthesiology, 102, 276, 10.1097/00000542-200502000-00007

Avidan, 2005, Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass, J Thorac Cardiovasc Surg, 130, 107, 10.1016/j.jtcvs.2004.10.045

Koster, 2003, High antithrombin III levels attenuate hemostatic activation and leukocyte activation during cardiopulmonary bypass, J Thorac Cardiovasc Surg, 126, 906, 10.1016/S0022-5223(03)00392-1

Lemmer, 2002, Antithrombin III concentrate to treat heparin resistance in patients undergoing cardiac surgery, J Thorac Cardiovasc Surg, 123, 213, 10.1067/mtc.2002.119060

Andrew, 1987, Development of the human coagulation system in the full-term infant, Blood, 70, 165, 10.1182/blood.V70.1.165.165

Odegard, 2009, Prospective longitudinal study of coagulation profiles in children with hypoplastic left heart syndrome from stage I through Fontan completion, J Thorac Cardiovasc Surg, 137, 934, 10.1016/j.jtcvs.2008.09.031

Odegard, 2007, Evaluation of the coagulation system in children with two-ventricle congenital heart disease, Ann Thorac Surg, 83, 1797, 10.1016/j.athoracsur.2006.12.030

Hakacova, 2008, Disturbances of coagulation in neonates with functionally univentricular physiology prior to the first stage of surgical reconstruction, Cardiol Young, 18, 397, 10.1017/S1047951108002400

Bassler, 2006, Antithrombin for respiratory distress syndrome in preterm infants, Cochrane Database Syst Rev, 10.1002/14651858.CD005383.pub2

Schmidt, 1998, A placebo-controlled randomized trial of antithrombin therapy in neonatal respiratory distress syndrome, Am J Respir Crit Care Med, 158, 470, 10.1164/ajrccm.158.2.9712116

Fulia, 2003, Can the administration of antithrombin III decrease the risk of cerebral hemorrhage in premature infants?, Biol Neonate, 83, 1, 10.1159/000067005